NWLA March Dinner Meeting
2Johns Steak & Seafood
2151 Airline Drive
Bossier City, LA 71111
Tuesday, March 10, 2026 at 6:00pm CT - 9:00pm CT
Info
Topic
IMAAVY™ (nipocalimab-aahu): An FDA-approved option for your patients with gMG
Additional Information
IMAAVY™ (nipocalimab-aahu) is a neonatal Fc receptor (FcRn) blocker indicated for the treatment of generalized
myasthenia gravis (gMG) in adult and pediatric patients 12 years of age and older who are anti-acetylcholine
receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive.
Please arrive 30 minutes prior to event time in order to check in.
******Please RSVP at MyDomeProgramRegistration.com
Enter Meeting Code: 2026-00398
RSVP online by: 2/28/2026
Please note that your email will be required for registration. The information you provide will only be used to facilitate your attendance at this program. If you have questions about this program, please contact your Johnson & Johnson representative. We look forward to your participation in this informative discussion. Sponsored by Johnson & Johnson.